CLINICAL CHARACTERISTICS OF PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND UNDERGOING SGLT2I THERAPY

被引：0
|
作者：
Alcidi, G.
Pugliese, R.
Ioannoni, S.
Romano, M.
Granatiero, M.
Diomede, D.
Benvenuto, M.
Correale, M.
Brunetti, N.
Gronda, E.
Iacoviello, M.
机构：
[1] AOU Policlin Foggia, SC Cardiol, Foggia, Italy
[2] Area Cardiorenale & Metabol ANMCO, Teramo, Italy
[3] Area Cardiorenale & Metabol ANMCO, Milan, Italy
[4] AOU Policlin Foggia, Area Cardiorenale & Metabol ANMCO, SC Cardiol, Foggia, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P468
引用
收藏
页数：1
相关论文
共 50 条
  • [1] UP TO 12 MONTH TRENDS IN CLINICAL AND BIOCHEMICAL PARAMETERS AFTER SGLT2I THERAPY IN PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION
    Pugliese, R.
    Alcidi, G.
    Ioannoni, S.
    Diomede, D.
    Romano, M.
    Correale, M.
    Benvenuto, M.
    Gronda, E.
    Brunetti, N.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [2] Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States
    Pierce, J. B.
    Vaduganathan, M.
    Fonarow, G. C.
    Ikeaba, U.
    Chiswell, K.
    Huang, J.
    Linganathan, K.
    Mcdermott, J.
    Greene, S. J. Stephen
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 66 - 67
  • [3] ECHOCARDIOGRAPHIC FINDING BETWEEN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION IN TREATMENT WITH ARNI AND SGLT2I
    Ceci, Vincenzo
    Mazzeo, Pietro
    Ferrara, Salvatore
    Nardella, Luigi
    Tricarico, Lucia
    Alfieri, Simona
    Croella, Francesca
    Amatruda, Marco
    Granatiero, Michele
    D'alessandro, Damiano
    Di Nunno, Nicola
    Pugliese, Rosanna
    Noviello, Giulia
    Correale, Michele
    Stabile, Egenio
    Stabile, Eugenio
    Iacoviello, Massimo
    Di Biase, Matteo
    Brunetti, Natale D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [4] SGLT2i in heart failure with reduced ejection fraction: benefits in real life?
    Sanchez Gonzalez, V. Virtudes
    Flano-Lombardo, R.
    Esteve-Ruiz, I.
    Cortez, G.
    Aranda-Dios, A.
    Duran-Torralba, C.
    Rangel-Sousa, D.
    Sobrino-Marquez, J. M.
    Grande-Trillo, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 72 - 73
  • [5] CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN THERAPY WITH SGLT2I RELATED TO THE HEART FAILURE OUTPATIENT
    Benvenuto, M.
    Iacoviello, M.
    Gronda, E.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [6] SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this
    Soh, B. W. T.
    Balfe, C.
    O'Brien, K.
    Glasgow, J.
    Forkin, A.
    Sim, W. H.
    Muradagha, H.
    Abbas, S.
    Arnous, S.
    Kiernan, T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 952 - 952
  • [7] SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction
    Nuzzi, Vincenzo
    Manca, Paolo
    Parisi, Francesca
    Madaudo, Cristina
    Sciacca, Sergio
    Cannizzo, Noemi
    Mule, Massimiliano
    Cipriani, Manlio G.
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (11)
  • [8] Baseline characteristics and alterations after initiation of therapy with SGLT2i in a real-world heart failure with reduced ejection fraction population
    Stavrati, A.
    Polymeropoulos, K.
    Ioannidis, P.
    Kleitsioti, P.
    Lazaridis, P.
    Zarifis, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 163 - 163
  • [9] Risk of genitourinary infection similar among SGLT2i in patients with heart failure and preserved ejection fraction
    Reactions Weekly, 2024, 2011 (1) : 10 - 10
  • [10] Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review
    Nisha B. Jhalani
    Advances in Therapy, 2022, 39 : 3472 - 3487
12345